Stay updated on Immunotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ARC-7 study record for immunotherapies in PD-L1-positive non-small cell lung cancer is displayed, with trial design, participation criteria, outcomes, and study locations. It also includes information on sharing participant data and related study documents.
    Difference
    70%
    Check dated 2026-11-09T13:22:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T12:58:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice links to transition updates and FAQs and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T14:36:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:52:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-12T15:55:57.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The 403 error page and its Home link were removed, enabling the study details page to display its content again.
    Difference
    0.5%
    Check dated 2026-09-28T19:55:42.000Z thumbnail image

Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.